Qritive Launches QAi Prostate: Advanced AI-Powered Prostate Cancer Diagnosis Tool for Pathologists
QAi Prostate leverages advanced machine learning algorithms to accurately identify and classify malignant and benign areas in prostate biopsies, improving diagnostic accuracy and patient outcomes SINGAPORE, March 13, 2023 /PRNewswire/ -- Qritive, a leading provider of digital pathology solutions, announced the launch of a new AI (Artificial Intelligence) module, QAi Prostate, for prostate cancer diagnosis. Using advanced machine...
Everest Medicines Announces Silicon Valley Bank Developments Have Minimal Impact on Company
SHANGHAI, March 13, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing, manufacturing and commercializing transformative pharmaceutical products and vaccines in Greater China and other parts of Asia, would like to announce that it considers its exposure to any liquidity concerns at Silicon Valley Bank (SVB) to be immaterial. The company's cash held at SVB...
AnnJi Pharmaceutical Announced A Licensing Agreement With Avenue Therapeutics To Develop And Commercialize AJ201, A First-In-Class Clinical Asset For The Treatment Of Kennedy’s Disease
TAIPEI, March 10, 2023 /PRNewswire/ -- AnnJi Pharmaceutical Co. (AnnJi) has entered into an exclusive license agreement with Avenue Therapeutics Inc. (Avenue, NASDAQ: ATXI) for the development and commercialization of AJ201 in the U.S., Canada, European Union, Great Britain, and Israel for spinal and bulbar muscular atrophy (SBMA), also known as Kennedy's Disease. Under the terms of the license...
Success for Surglasses Technology! First AR Surgery Completed in the United States
TAICHUNG, Taiwan, March 10, 2023 /PRNewswire/ -- Surglasses/Caduceus S from Taiwan Main Orthopaedic Biotechnology Co., Ltd. Achieves Landmark Success with Caduceus S AR Spine Navigation System for First Augmented Reality Surgery in the US using 2D C-Arm Imaging. Surglasses has achieved a significant milestone in the field of spinal surgery with the completion of the first augmented reality (AR) surgery in...
Safeguard “Children of the Stars” – Soul App’s New Campaign Inspires Young Users
SHANGHAI, March 10, 2023 /PRNewswire/ -- "Thank you all. It was heartwarming. (We will) keep going," said a message left by a parent of an autistic child in an online group chat party. In China, children with autism are also known as "children of the stars", due to the different way in which they communicate and perceive the world,...
Allorion Therapeutics, a next-generation precision medicine company focusing on oncology and autoimmune diseases, raises $50 million Series B financing
BOSTON, March 10, 2023 /PRNewswire/ -- Allorion Therapeutics ("Allorion"), a biotech company focusing on next-generation precision medicine for oncology and autoimmune diseases, announces the completion of a $50 million Series B financing round, co-led by INCE Capital and Qiming Venture Partners, with participation from TF Capital, Long River Investment (LRI), 3SBio, Octagon Capital, and Elikon Venture. Since its establishment...
uLab Systems™ Launches AI Platform Innovations and Receives Superior Ratings for its uAssist™ Treatment Planning Assistance Service
MEMPHIS, Tenn., March 10, 2023 /PRNewswire/ -- uLab Systems, creator of the uSmile™ clear aligner system, announces the release of a new streamlined version of its uDesign® 7 software along with survey results stating a majority of its customers find the uAssist treatment planning assistance service is more efficient and results...
NCODA International Executive Council to Advance Medically Integrated Oncology Worldwide
CAZENOVIA, N.Y., March 10, 2023 /PRNewswire/ -- NCODA a non-profit organization whose Mission is to empower the medically-integrated oncology team to deliver positive, patient-centered outcomes is proud to announce the formation of its International Executive Council (IEC). The IEC will provide insight and leadership to NCODA regarding meeting the ever-changing needs of oncology...
Hugel Nominates Suk-yong Cha as Non-Executive Director
Hugel's 22nd General shareholders' meeting to take place on March 30th Proposed appointment of Suk-yong Cha as new non-executive director as an agenda item SEOUL, South Korea, March 9, 2023 /PRNewswire/ -- Hugel, a global total medical aesthetic company, announced on March 9th that it will present...
Havas Health & You Launches Dynamic Value and Access Consultancy, Archipelago
NEW YORK, March 9, 2023 /PRNewswire/ -- The success of life sciences brands depends on their ability to navigate complexities around value, access, pricing, and reimbursement. To help clients solve for these issues, Havas Health & You publicly announced the launch of its first standalone value and access consultancy, Archipelago. This global...
